Logo of National Eczema Association mobile menu icon
Icon link to National Eczema's Instagram feed. Icon link to National Eczema's YouTube channel. Icon link to National Eczema's Facebook page. Icon link to National Eczema's Twitter feed. Icon link to National Eczema's inspire.com page. Search Icon to search the site

Get the tools and support you need to best manage your eczema

  • This field is for validation purposes and should be left unchanged.

Eczema Matters

Browsing Articles Tagged with the Topic ofdupilumab

Researchers investigate Dupixent side effects

Researchers investigate Dupixent side effects

In addition to conjunctivitis, a widely reported side effect of the atopic dermatitis biologic Dupixent (dupilumab), res...

Has Dupixent delivered on its promise? The eczema community offers honest feedback

Has Dupixent delivered on its promise? The eczema community offers honest feedback

More than two years after the FDA’s approval of the first biologic treatment for atopic dermatitis, many patients taki...

Two new atopic dermatitis biologics show promising results in phase IIb clinical trials

Two new atopic dermatitis biologics show promising results in phase IIb clinical trials

Galderma’s nemolizumab and Dermira’s lebrikizumab are two new biologics for atopic dermatitis that are working their...

Should I go on dupilumab if I’m thinking about getting pregnant?

Should I go on dupilumab if I’m thinking about getting pregnant?

There are lots of unknowns when it comes to biologics and pregnancy. That's why it's important to ask questions — and ...

Colorado researchers urge raising the bar for treating severe eczema

Colorado researchers urge raising the bar for treating severe eczema

The researchers suggest doctors combine basic skincare techniques with cutting-edge treatments to maximize the well-bein...

Dupixent may soon be approved for teenagers

Dupixent may soon be approved for teenagers

Dupixent, a biologic drug for moderate to severe AD, may soon be available to patients aged 12 to 18 if the treatment co...

NEA Celebrates Another Win for Access to New Atopic Dermatitis Therapy Dupixent

NEA Celebrates Another Win for Access to New Atopic Dermatitis Therapy Dupixent

ICER, a nonprofit that conducts independent reviews on clinical effectiveness and value of treatments, found Dupixent t...

Never Lose Hope

Never Lose Hope

A newly approved treatment finally brings relief to a woman who's coped with severe eczema for more than 70 years....

Q & A: Introducing Biologics with Dr. Paul Yamauchi

Q & A: Introducing Biologics with Dr. Paul Yamauchi

In March, the FDA approved Dupixent, the first biologic medication for adults with moderate to severe atopic dermatitis....

First Biologic Approved for Moderate to Severe Atopic Dermatitis

First Biologic Approved for Moderate to Severe Atopic Dermatitis

The U.S. Food and Drug Administration approved Dupixent (dupilumab), the first biologic medication for adults with moder...

Top Advances in Eczema Research in 2016

Top Advances in Eczema Research in 2016

There are different kinds of research when it comes to eczema. There is scientific research that tries to understand the...

Eczema Awareness Month Kicks-Off with Groundbreaking News

Eczema Awareness Month Kicks-Off with Groundbreaking News

The first biologic treatment for adults with atopic dermatitis may come to market in spring 2017....